- BioCentury,
the Bernstein Report on BioBusiness™
BioCentury’s flagship journal, provides analysis, interpretation
and commentary on industry development, corporate performance, clinical
and commercial product development, emerging technology, public policy
and financial markets. Delivered each Monday via email. [see
sample]
- BioCentury
Extra The concise and authoritative
international newspaper for biotech and pharma is compiled, written and updated
throughout each business day by BioCentury’s experienced editors
and analysts. Always available online. [see
sample]
- BioCentury
Part II The
most complete compendium of corporate, clinical and financial transactions,
providing an efficient surveillance system for deals, regulatory events,
clinical reports and financing activity. Delivered each Monday via
email. [see
sample]
- BioCentury
Quarterly Stock Roundup
Tracks over 500 public biotech companies in the US, Europe, Canada
and Asia-Pacific. This complete overview records the performance of
44 industry subgroups, the BioCentury 100 Index and
other benchmark indices and each quarter's fundraising activity. Delivered
to all subscribers at the end of each quarter. [see
sample]
|